Results 31 to 40 of about 1,626 (189)

The Effect of Ramosetron on Remifentanil in Preventing Emergence Cough from Sevoflurane Anesthesia in Female Patients

, 2022
Background: Remifentanil reduces cough during extubation. Ramosetron, a 5-HT3 receptor antagonist, is a potent antiemetic. Regarding the antitussive property of 5-HT receptor agonists, ramosetron can mediate the cough reflex by increasing the ...
이혜선, Sung Yong Park, Ji Ho Kim, Hye Sun Lee, Lee, GY, Kim, JH, Ga Yun Lee, Lee, HS, Park, SY   +8 more
core   +2 more sources

Comparison of equipotent doses of Ramosetron, Ondansetron, and sub-hypnotic dose of Propofol for prevention of postoperative nausea and vomiting in laparoscopic cholecystectomy

Journal of Anaesthesiology Clinical Pharmacology, 2021
Background and Aims: For prevention of Postoperative nausea vomiting (PONV) in laparoscopic surgery, ramosetron is a selective 5-HT3 receptor antagonist with higher receptor affinity and slow dissociation than ondansetron.
Shilpa Amol Acharya, Kalyani Nilesh Patil   +1 more
doaj   +1 more source

Comparison of Intravenous Ondansetron, Ramosetron and Palonosetron for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Total Abdominal Hysterectomy: A RCT [PDF]

Journal of Clinical and Diagnostic Research, 2021
Introduction: Postoperative Nausea and Vomiting (PONV) poses a major problem in anaesthetic practice and is associated with various untoward consequences.
Sumanth Tarigonda, Abhinaya Manem, Kailasanath Udupi Shenoy, Arun Kumar Handigodu Duggappa, Rohith Krishna   +4 more
doaj   +1 more source

The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy [PDF]

Korean Journal of Anesthesiology, 2011
BackgroundPostoperative nausea and vomiting (PONV) frequently develops in patients undergoing thyroidectomy, and propofol-based total intravenous anesthesia (TIVA) has been reported to reduce the incidence of PONV.
Dong Chul Lee, Hyun Jeong Kwak, Hong Soon Kim, Sung Ho Choi, Ji Yeon Lee   +4 more
doaj   +1 more source

A Scoping Review of 5-HT₃ Antagonist Antiemetic Medication Safety in the Management of Nausea and Vomiting of Pregnancy. [PDF]

Pharmacoepidemiol Drug Saf
ABSTRACT Purpose The prescribing of 5‐hydroxytryptamine 3 receptor and type 3 serotonin receptor (5‐HT3) antagonists, particularly ondansetron, for nausea and vomiting in pregnancy (NVP) has increased globally. However, evidence on the safety of these medications in pregnancy remains unclear.
Morgan S, Quintrell E, Russell DJ, Rhaman A, Gebremedhin A, Wyrwoll CS, Kelty E.   +6 more
europepmc   +2 more sources

Inhibitory Effects of Ramosetron, a Potent and Selective 5-HT3–Receptor Antagonist, on Conditioned Fear Stress–Induced Abnormal Defecation and Normal Defecation in Rats: Comparative Studies With Antidiarrheal and Spasmolytic Agents

Journal of Pharmacological Sciences, 2008
We examined the effect of ramosetron, a potent serotonin (5-HT)3-receptor antagonist for irritable bowel syndrome with diarrhea, on conditioned fear stress (CFS)-induced defecation and normal (non-stressed) defecation in rats and compared ramosetron with
Takuya Hirata, Toshiyuki Funatsu, Yoshihiro Keto, Shinobu Akuzawa, Masao Sasamata, Keiji Miyata   +5 more
doaj   +1 more source

Effect of dexamethasone and ramosetron on the prevention of postoperative nausea and vomiting in low-risk patients: a randomized, double-blind, placebo-controlled, multicenter trial

BMC Anesthesiology, 2023
Background Several studies have investigated the effect of antiemetics on postoperative nausea and vomiting (PONV) in high-risk groups. However, few studies have investigated the effect of antiemetics in patients at low risk of developing PONV.
Jong-Ho Kim, Jin-Sun Kim, Yeong-Gwan Jeon, Jangho Bae, Kiyoung Shin, Byeongmun Hwang   +5 more
doaj   +1 more source

A randomized, double-blind study to evaluate the efficacy of ramosetron and palonosetron for prevention of postoperative nausea and vomiting after gynecological laparoscopic surgery [PDF]

Korean Journal of Anesthesiology, 2013
BackgroundPostoperative nausea and vomiting (PONV) is a common complication after anesthesia and surgery; 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists have been considered as a first-line therapy.
Soo Kyoung Park, Eun Jung Cho, Sung Hee Kang, Young Jun Lee, Dal-Ah Kim   +4 more
doaj   +1 more source

Effects of Ramosetron on Nausea and Vomiting Following Spinal Surgery: A Meta-Analysis

Current Therapeutic Research, 2022
: Background: Spinal surgery is associated with severe pain within the first few days after surgery. Opioids are commonly used to control postoperative pain, but these can lead to postoperative nausea and vomiting (PONV).
Yiyun Lin, MD, Sun Tiansheng, MMS, Zhang Zhicheng, Chen Xiaobin, Li Fang   +4 more
doaj   +1 more source

Comparison of ramosetron, ondansetron, and granisetron in attenuating maternal hypotension after spinal anesthesia in patients undergoing lower segment caesarean section: A prospective, randomized, double-blinded study

Bali Journal of Anesthesiology, 2022
Background: Spinal anesthesia (SA) has many advantages in lower segment caesarean section (LSCS), but hypotension is the main issue that can be managed in different ways.
Suvina Narendra, Dipali Singh, Jay Prakash, Shio Priye, Shailesh Kumar, Bharati Bharati   +5 more
doaj   +1 more source